HO95
Phase 3 Completed
1,503 enrolled
MYELAXAT
Phase 3 Completed
108 enrolled
Aprepitant- and Olanzapine- Containing Anti-emetic Regimens With High Dose Melphalan
Phase 3 Completed
52 enrolled 11 charts
Thalidomide and Prednisone After Autologous Stem Cell Transplantation Multiple Myeloma
Phase 3 Completed
332 enrolled 11 charts
Combination Chemotherapy With or Without PSC 833 in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 3 Completed
Denosumab Compared to Zoledronic Acid in the Treatment of Bone Disease in Patients With Multiple Myeloma
Phase 3 Completed
1,718 enrolled 22 charts
BMT CTN 0102
Phase 3 Completed
710 enrolled 19 charts
Study of Vorinostat (MK-0683) or Placebo, in Combination With Bortezomib in Participants With Multiple Myeloma (MK-0683-088 AMN)
Phase 3 Completed
637 enrolled 15 charts
Dalteparin to Prevent Complications in Cancer Patients Receiving Chemotherapy Through a Catheter
Phase 3 Completed
Darbepoetin Alfa Compared With Epoetin Alfa in Treating Anemia in Patients Receiving Chemotherapy for Cancer
Phase 3 Completed
14 enrolled
A Randomized Trial to Compare Busulfan + Melphalan 140 mg/m2 With Melphalan 200 mg/m2 as Preparative Regimen for Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma
Phase 3 Completed
205 enrolled 11 charts
Treatment for Chronic Pain in Patients With Advanced Cancer
Phase 3 Completed
87 enrolled
Combination Chemotherapy in Treating Patients With Multiple Myeloma
Phase 3 Completed
595 enrolled
PANORAMA-1
Phase 3 Completed
767 enrolled 17 charts
Study to Evaluate the Safety and Efficacy of Pomalidomide Monotherapy in Subjects With Refractory or Relapsed Refractory Multiple Myeloma
Phase 3 Completed
74 enrolled 17 charts
IFM/DFCI2009
Phase 3 Completed
700 enrolled
Thalidomide for Multiple Myeloma
Phase 3 Completed
27 enrolled
Melphalan, Prednisone and Thalidomide Versus Melphalan and Prednisone in Elderly Myeloma Patients
Phase 3 Completed
400 enrolled
Baclofen-Amitriptyline Hydrochloride-Ketamine Gel in Treating Peripheral Neuropathy Caused by Chemotherapy in Patients With Cancer
Phase 3 Completed
208 enrolled 12 charts
Cyclosporine Eye Drops in Preventing Graft-Versus-Host Disease of the Eye in Patients Who Have Undergone Donor Stem Cell Transplant for Hematologic Cancer or Bone Marrow Failure Disorder
Phase 3 Completed
164 enrolled 8 charts
American Ginseng in Treating Patients With Fatigue Caused by Cancer
Phase 3 Completed
364 enrolled 29 charts
Epoetin Alfa in Treating Anemia in Patients With Solid Tumors
Phase 3 Completed
365 enrolled
Ondansetron in Treating Patients With Advanced Cancer and Chronic Nausea and Vomiting Not Caused by Cancer Treatment
Phase 3 Completed
100 enrolled
Low-Dose Melphalan and Dexamethasone Compared With High-Dose Melphalan Followed By Autologous Stem Cell Transplant in Treating Patients With Primary Systemic Amyloidosis
Phase 3 Completed
89 enrolled 11 charts
UARK 2005-01 Study of Velcade, Thalidomide, and Dexamethasone (VTD) With or Without Adriamycin® in Relapsed/Refractory Patients
Phase 3 Completed
180 enrolled
S0232 Dexamethasone With or Without Lenalidomide in Treating Patients With Previously Untreated Stage I, Stage II, or Stage III Multiple Myeloma
Phase 3 Completed
198 enrolled 6 charts
Dexamethasone With or Without Thalidomide in Treating Patients With Newly Diagnosed Multiple Myeloma
Phase 3 Completed
Dexamethasone With or Without Oblimersen in Treating Patients With Relapsed or Refractory Multiple Myeloma
Phase 3 Completed
Dexamethasone and Chemotherapy With or Without Plasma Exchange in Patients With Newly Diagnosed Multiple Myeloma and Acute Kidney Failure
Phase 3 Completed
280 enrolled
Epoetin Alfa in Treating Anemia in Patients With Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma and Anemia Caused By Chemotherapy
Phase 3 Completed
275 enrolled
Combination Chemotherapy in Treating Patients With Stage II or Stage III Multiple Myeloma
Phase 3 Completed
200 enrolled
Antifungal Therapy for Fever and Neutropenia in Patients Receiving Treatment for Hematologic Cancer
Phase 3 Completed
St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer
Phase 3 Completed
Prevention of Infection in Patients With Hematologic Cancer and Persistent Fever Caused by a Low White Blood Cell Count
Phase 3 Completed
859 enrolled
Opioid Titration Order Sheet or Standard Care in Treating Patients With Cancer Pain
Phase 3 Completed
98 enrolled 14 charts
Zoledronate With or Without Thalidomide in Treating Patients With Early Stage Multiple Myeloma
Phase 3 Completed
68 enrolled 16 charts
Melphalan Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Phase 3 Completed
Darbepoetin Alfa With or Without Iron in Treating Anemia Caused By Chemotherapy in Patients With Cancer
Phase 3 Completed
502 enrolled 30 charts
Melphalan With or Without Holmium Ho 166 DOTMP Followed by Peripheral Stem Cell Transplantation in Treating Patients With Multiple Myeloma
Phase 3 Completed
Study of Bortezomib and Revlimid™ for Patients Relapsing or Progressing on Total Therapy II
Phase 3 Completed
315 enrolled